Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hevylite® FDA Cleared to Help Monitor Patients with IgG and IgA Myeloma

Published: Friday, April 11, 2014
Last Updated: Friday, April 11, 2014
Bookmark and Share
Hevylite® measures the concentration of each immunoglobulin subtype.

Binding Site’s novel laboratory blood assays for intact immunoglobulins, Hevylite®, have recently become the only automated immunoassay cleared by the FDA for monitoring IgA and IgG Multiple Myeloma patients.

Hevylite® measures the concentration of each immunoglobulin subtype i.e. IgGκ, IgGλ, IgAκ, IgAλ, IgMκ, IgMλ using a rapid, quantitative method. These measurements are used to produce immunoglobulin heavy/light chain ratios, e.g. IgGκ/IgGλ, similar to Free Light Chain κ/λ ratios when using Freelite®.

The assays can overcome issues with serum protein electrophoresis including problems due to co-migration (commonly seen in IgA myeloma patients) and inaccuracies due to low or high levels of monoclonal protein.

In addition, reports suggest these assays may aid in identifying residual disease and relapse in some patients. Uniquely, Hevylite® also gives information about the uninvolved heavy/light chain pair e.g. IgAλ in an IgAκ myeloma patient.

Hevylite® can help when results from serum protein electrophoresis (SPE) and immunofixation electrophoresis (IFE) are difficult to interpret; this includes problems due to co-migration of monoclonal bands, lower sensitivity/high variation at low levels of monoclonal protein (<10g/L) and non-linearity due to gel dye saturation.

In a number of publications, Hevylite® showed disease relapse in Multiple Myeloma patients some months before a monoclonal protein could be detected using SPE and IFE. Results indicate that it is the unique ability to measure suppression of the uninvolved Hevylite® pair which adds sensitivity to this assay both for relapse and in detecting residual disease.

These assays are also CE marked and currently in routine use in a number of countries. Hevylite® is being evaluated by many institutions worldwide and has been the subject of more than 20 papers and around 200 abstract and poster publications.

Hevylite® is also mentioned in prestigious guidelines published by the British Committee for Standards in Haematology. This reflects the increasing number of publications showing the benefits of Hevylite® in a laboratory and clinical setting.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
COPD Linked to Increased Bacterial Invasion
Persistent inflammation in COPD may result from a defect in the immune system that allows airway bacteria to invade deeper into the lung.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
Vaccinations Are More Effective When Administered In The Morning
Research from the University of Birmingham shows that influenza vaccinations have more protective responses when administered in the morning.
Secrets of a Deadly Virus Family Revealed
Scripps Research scientists uncover the glycoprotein structure of LCMV. The findings could guide development of treatments for Lassa fever.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
Reduced Immune Response Causes Flu Deaths in Older Adults
Yale study suggests that immune response to flu causes death in older people, not the virus.
Exposure To Routine Viruses Makes Mice Better Test Subjects
Study shows that infections make mouse immune system act more like that in humans.
Immune Booster Tested in Advanced Merkel Cell Cancer
The immunotherapy drug produced durable responses in many patients.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!